Core Insights - The establishment of MYCO ONE Global marks a significant step towards sustainable transformation in the global food industry, focusing on the development and commercialization of mycoprotein-based products [1][10] - The partnership aims to leverage the strengths of both companies to meet the growing demand for sustainable and healthy protein solutions in the market [10] Company Overview - MYCO ONE Global is a joint venture between 富祥药业's wholly-owned subsidiary in Singapore and MYCO ONE d.o.o., an innovative food company based in Slovenia [1] - The company will focus on the development, production, and marketing of mycoprotein products, particularly the "未冉蛋白" [1][2] Product Development - The core product, "未冉蛋白," is a mycoprotein derived from filamentous fungi, recognized for its high protein content and nutritional benefits, including 18 essential amino acids and dietary fiber [2] - The product is free from antibiotics, pesticide residues, and hormones, ensuring food safety and health for consumers [2] Market Strategy - MYCO ONE Global plans to penetrate mainstream retail channels in Europe, including major supermarket chains such as ALDI, SPAR, Kaufland, and Metro [4] - The company aims to expand its market presence from Europe to the Americas and Asia, providing high-nutrition, sustainable mycoprotein ingredients and customized applications [4][12] Product Launch - The initial product offerings will include MYCO Juicy Burger (beef flavor) and MYCO Chicky Burger (chicken flavor), designed to enhance the sensory experience while maintaining health attributes [5][7] - The MYCO Juicy Burger has received a high sensory evaluation score of 18.6 out of 20, indicating its readiness for mainstream retail [7] Strategic Implications - This collaboration represents a significant integration of Chinese fermentation technology with European food branding and distribution systems, addressing global consumer demands for healthy and sustainable protein sources [10] - The establishment of MYCO ONE Global signifies a strategic shift for 富祥药业 from a raw material producer to a global player in food technology, leveraging its expertise in microbial fermentation [12]